Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Journal of Oncology|March 6, 2026
Mechanisms of chemoresistance in diffuse large B‑cell lymphoma and novel therapeutic strategies (Review)Mengdi Wan, Xi Wang, Bin Luo, et al.
Bioengineered|October 21, 2020
A new metabolic signature contributes to disease progression and predicts worse survival in melanomaMengdi Wan, Binyu Zhuang, Xiao Dai, et al.
ACS Macro Letters|February 3, 2023
Coumarinacyl Anilinium Salt: A Versatile Visible and NIR Photoinitiator for Cationic and Step-Growth PolymerizationsLongji Li, Mengdi Wan, Zhiquan Li, et al.
International Immunopharmacology|July 9, 2025
Machine learning-driven programmed cell death signature for prognosis and drug candidate discovery in diffuse large B-cell lymphoma: Multi-cohort study and experimental validationBin Luo, Le Yu, Wei Zhang, et al.
Biochemical Pharmacology|October 5, 2025
Targeting CREB1/p300-mediated RGS1 expression in tumor-associated macrophages improves the efficacy of anti-PD-1 therapy in triple-negative breast cancerXiangyu Liu, Xingyan Ju, Ronghui Yuan, et al.
Neoplasia (New York, N.Y.)|February 4, 2025
SLC31A1 promotes chemoresistance through inducing CPT1A-mediated fatty acid oxidation in ER-positive breast cancerXudong Li, Jingjing Ge, Mengdi Wan, et al.
Clinical and Experimental Medicine|March 30, 2024
Development and validation of a novel prognostic nomogram for advanced diffuse large B cell lymphomaMengdi Wan, Wei Zhang, He Huang, et al.
Pageof 1